Importer of Controlled Substances Application: Lipomed, 17623-17627 [2023-05916]

Download as PDF 17623 Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices approved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2023–05911 Filed 3–22–23; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1159] Importer of Controlled Substances Application: Lipomed Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 24, 2023. Such persons may also file a written request for a hearing on the application on or before April 24, 2023. DATES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If ADDRESSES: you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on February 9, 2023 Lipomed, 150 Cambridepark Drive, Suite 705, Cambridge, Massachusetts 02140–2300, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code 3-Fluoro-N-methylcathinone (3–FMC) ................................................................................................................................... Cathinone .............................................................................................................................................................................. Methcathinone ....................................................................................................................................................................... 4-Fluoro-N-methylcathinone (4–FMC) ................................................................................................................................... Pentedrone (a-methylaminovalerophenone) ......................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .......................................................................................................................... 4-Methyl-N-ethylcathinone (4–MEC) ..................................................................................................................................... Naphyrone ............................................................................................................................................................................. N-Ethylamphetamine ............................................................................................................................................................. N,N-Dimethylamphetamine .................................................................................................................................................... Fenethylline ........................................................................................................................................................................... Aminorex ................................................................................................................................................................................ 4-Methylaminorex (cis isomer) .............................................................................................................................................. Gamma Hydroxybutyric Acid ................................................................................................................................................. Methaqualone ........................................................................................................................................................................ Mecloqualone ........................................................................................................................................................................ JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ........................................................................................................ SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ...................................................... ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ................... 5-Fluoro-UR–144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) ................... AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ........................... JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ............................................................................................................................ MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............................ FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide ............................................... THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ....................................................................... 5F–AB–PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ............................ AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ..................... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .............. 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .................................................... 5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............ ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ....................................... Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido) 3,3-dimethylbutanoate) ................................................................. MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) .............. N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide) .................................................................................... APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) .................................................................. 5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................................ JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ........................................................................................................ 1-(5-Fluoropentyl)-1H-indazole-3-carboxamide ..................................................................................................................... 5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ..................... 4–CN–CUMYL–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboximide). SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ......................................................................... JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .................................................................................... VerDate Sep<11>2014 19:23 Mar 22, 2023 Jkt 259001 PO 00000 Frm 00108 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1 Schedule 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 1585 1590 2010 2565 2572 6250 7008 7010 7011 7012 7019 7020 7021 7023 7024 7025 7031 7032 7033 7034 7035 7036 7042 7044 7047 7048 7049 7081 7083 7085 7089 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 7104 7118 I I 17624 Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ........................................................................................................... UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ...................................................................... JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................. JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ................................................................................................ AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................................. JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ............................................................................................................ NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................... PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ....................................................................................................... 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................................. 4-methyl-alpha-ethylaminopentiophenone (4–MEAP) ........................................................................................................... N-ethylhexedrone .................................................................................................................................................................. Alpha-ethyltryptamine ............................................................................................................................................................ Ibogaine ................................................................................................................................................................................. CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ...................................................................... CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................................ Lysergic acid diethylamide .................................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .................................................................................................... Marihuana extract .................................................................................................................................................................. Marihuana .............................................................................................................................................................................. Tetrahydrocannabinols .......................................................................................................................................................... Parahexyl ............................................................................................................................................................................... Mescaline ............................................................................................................................................................................... 2C–T–2, (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) ................................................................................................ 3,4,5-Trimethoxyamphetamine .............................................................................................................................................. 4-Bromo-2,5-dimethoxyamphetamine ................................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................ 4-Methyl-2,5-dimethoxyamphetamine ................................................................................................................................... 2,5-Dimethoxyamphetamine .................................................................................................................................................. JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ............................................................................................................ 2,5-Dimethoxy-4-ethylamphetamine ...................................................................................................................................... 3,4-Methylenedioxyamphetamine .......................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine ........................................................................................................................ N-Hydroxy-3,4-methylenedioxyamphetamine ........................................................................................................................ 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................. 3,4-Methylenedioxymethamphetamine .................................................................................................................................. 4-Methoxyamphetamine ........................................................................................................................................................ 5-Methoxy-N–N-dimethyltryptamine ...................................................................................................................................... Alpha-methyltryptamine ......................................................................................................................................................... Bufotenine .............................................................................................................................................................................. Diethyltryptamine ................................................................................................................................................................... Dimethyltryptamine ................................................................................................................................................................ Psilocybin ............................................................................................................................................................................... Psilocyn ................................................................................................................................................................................. 5-Methoxy-N,N-diisopropyltryptamine ................................................................................................................................... 4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) .................................................................................................. N-Ethyl-1-phenylcyclohexylamine .......................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .......................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ..................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .................................................................................................................................... N-Ethyl-3-piperidyl benzilate .................................................................................................................................................. N-Methyl-3-piperidyl benzilate ............................................................................................................................................... N-Benzylpiperazine ................................................................................................................................................................ 4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ........................................................................................................... 2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ........................................................................................................ 2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ........................................................................................................... 2C–H (2-(2,5-Dimethoxyphenyl) ethanamine) ....................................................................................................................... 2C–I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) .............................................................................................................. 2C–C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ........................................................................................................ 2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) .......................................................................................................... 2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ................................................................................................... 2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) .......................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................................. 25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .......................................................... 25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .......................................................... 25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ............................................................................................................ Butylone ................................................................................................................................................................................. Pentylone ............................................................................................................................................................................... N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .......................................................... a-PHP, alpha-Pyrrolidinohexanophenone ............................................................................................................................. a-PVP (alpha-pyrrolidinopentiophenone) .............................................................................................................................. a-PBP (alpha-pyrrolidinobutiophenone) ................................................................................................................................ PV8, alpha-Pyrrolidinoheptaphenone .................................................................................................................................... AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ......................................................................................................... VerDate Sep<11>2014 19:23 Mar 22, 2023 Jkt 259001 PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1 7122 7144 7173 7200 7201 7203 7221 7222 7225 7245 7246 7249 7260 7297 7298 7315 7348 7350 7360 7370 7374 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7443 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7543 7544 7545 7546 7548 7694 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 17625 Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code Norfentanyl ............................................................................................................................................................................ Acetyldihydrocodeine ............................................................................................................................................................. Benzylmorphine ..................................................................................................................................................................... Codeine-N-oxide .................................................................................................................................................................... Cyprenorphine ....................................................................................................................................................................... Desomorphine ....................................................................................................................................................................... Etorphine (except HCl) .......................................................................................................................................................... Codeine methylbromide ......................................................................................................................................................... Dihydromorphine ................................................................................................................................................................... Difenoxin ................................................................................................................................................................................ Heroin .................................................................................................................................................................................... Hydromorphinol ..................................................................................................................................................................... Methyldesorphine .................................................................................................................................................................. Methyldihydromorphine ......................................................................................................................................................... Morphine methylbromide ....................................................................................................................................................... Morphine methylsulfonate ..................................................................................................................................................... Morphine-N-oxide .................................................................................................................................................................. Myrophine .............................................................................................................................................................................. Nicocodeine ........................................................................................................................................................................... Nicomorphine ......................................................................................................................................................................... Normorphine .......................................................................................................................................................................... Pholcodine ............................................................................................................................................................................. Thebacon ............................................................................................................................................................................... Acetorphine ............................................................................................................................................................................ Drotebanol ............................................................................................................................................................................. U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .................................................................... AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ........................................................................ MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ........................................................................................................ Acetylmethadol ...................................................................................................................................................................... Allylprodine ............................................................................................................................................................................ Alphacetylmethadol except levo-alphacetylmethadol ............................................................................................................ Alphameprodine ..................................................................................................................................................................... Alphamethadol ....................................................................................................................................................................... Benzethidine .......................................................................................................................................................................... Betacetylmethadol ................................................................................................................................................................. Betameprodine ...................................................................................................................................................................... Betamethadol ......................................................................................................................................................................... Betaprodine ........................................................................................................................................................................... Clonitazene ............................................................................................................................................................................ Dextromoramide .................................................................................................................................................................... Diampromide ......................................................................................................................................................................... Diethylthiambutene ................................................................................................................................................................ Dimenoxadol .......................................................................................................................................................................... Dimepheptanol ....................................................................................................................................................................... Dimethylthiambutene ............................................................................................................................................................. Dioxaphetyl butyrate .............................................................................................................................................................. Dipipanone ............................................................................................................................................................................. Ethylmethylthiambutene ........................................................................................................................................................ Etonitazene ............................................................................................................................................................................ Etoxeridine ............................................................................................................................................................................. Furethidine ............................................................................................................................................................................. Hydroxypethidine ................................................................................................................................................................... Ketobemidone ........................................................................................................................................................................ Levomoramide ....................................................................................................................................................................... Levophenacylmorphan .......................................................................................................................................................... Morpheridine .......................................................................................................................................................................... Noracymethadol ..................................................................................................................................................................... Norlevorphanol ...................................................................................................................................................................... Normethadone ....................................................................................................................................................................... Norpipanone .......................................................................................................................................................................... Phenadoxone ......................................................................................................................................................................... Phenampromide .................................................................................................................................................................... Phenoperidine ........................................................................................................................................................................ Piritramide .............................................................................................................................................................................. Proheptazine .......................................................................................................................................................................... Properidine ............................................................................................................................................................................ Racemoramide ...................................................................................................................................................................... Trimeperidine ......................................................................................................................................................................... Phenomorphan ...................................................................................................................................................................... Propiram ................................................................................................................................................................................ 1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................................ 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .................................................................................................................... Tilidine ................................................................................................................................................................................... Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ....................................................................................... VerDate Sep<11>2014 19:23 Mar 22, 2023 Jkt 259001 PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1 8366 9051 9052 9053 9054 9055 9056 9070 9145 9168 9200 9301 9302 9304 9305 9306 9307 9308 9309 9312 9313 9314 9315 9319 9335 9547 9551 9560 9601 9602 9603 9604 9605 9606 9607 9608 9609 9611 9612 9613 9615 9616 9617 9618 9619 9621 9622 9623 9624 9625 9626 9627 9628 9629 9631 9632 9633 9634 9635 9636 9637 9638 9641 9642 9643 9644 9645 9646 9647 9649 9661 9663 9750 9811 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 17626 Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code Para-Fluorofentanyl ............................................................................................................................................................... 3-Methylfentanyl .................................................................................................................................................................... Alpha-Methylfentanyl ............................................................................................................................................................. Acetyl-alpha-methylfentanyl ................................................................................................................................................... N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ............................................................................................. Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ..................................................................................... Butyryl Fentanyl ..................................................................................................................................................................... Para-fluorobutyryl fentanyl ..................................................................................................................................................... 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ............................................... 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ............................................................................................... Para-chloroisobutyryl fentanyl ............................................................................................................................................... Isobutyryl fentanyl .................................................................................................................................................................. Beta-hydroxyfentanyl ............................................................................................................................................................. Beta-hydroxy-3-methylfentanyl .............................................................................................................................................. Alpha-methylthiofentanyl ....................................................................................................................................................... 3-Methylthiofentanyl ............................................................................................................................................................... Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ................................................................... Thiofentanyl ........................................................................................................................................................................... Beta-hydroxythiofentanyl ....................................................................................................................................................... Para-methoxybutyryl fentanyl ................................................................................................................................................ Ocfentanil ............................................................................................................................................................................... Valeryl fentanyl ...................................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) ............................................................................... Cyclopropyl Fentanyl ............................................................................................................................................................. Cyclopentyl fentanyl .............................................................................................................................................................. Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ........................................................................................... Amphetamine ......................................................................................................................................................................... Methamphetamine ................................................................................................................................................................. Lisdexamfetamine .................................................................................................................................................................. Phenmetrazine ....................................................................................................................................................................... Methylphenidate .................................................................................................................................................................... Amobarbital ............................................................................................................................................................................ Pentobarbital .......................................................................................................................................................................... Secobarbital ........................................................................................................................................................................... Glutethimide ........................................................................................................................................................................... Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration (FDA). Nabilone ................................................................................................................................................................................. 1-Phenylcyclohexylamine ...................................................................................................................................................... Phencyclidine ......................................................................................................................................................................... ANPP (4-Anilino-N-phenethyl-4-piperidine) ........................................................................................................................... Phenylacetone ....................................................................................................................................................................... 1-Piperidinocyclohexanecarbonitrile ...................................................................................................................................... Alphaprodine .......................................................................................................................................................................... Anileridine .............................................................................................................................................................................. Cocaine .................................................................................................................................................................................. Codeine ................................................................................................................................................................................. Etorphine HCl ........................................................................................................................................................................ Dihydrocodeine ...................................................................................................................................................................... Oxycodone ............................................................................................................................................................................. Hydromorphone ..................................................................................................................................................................... Diphenoxylate ........................................................................................................................................................................ Ecgonine ................................................................................................................................................................................ Ethylmorphine ........................................................................................................................................................................ Hydrocodone ......................................................................................................................................................................... Levomethorphan .................................................................................................................................................................... Levorphanol ........................................................................................................................................................................... Isomethadone ........................................................................................................................................................................ Meperidine ............................................................................................................................................................................. Meperidine-intermediate-A .................................................................................................................................................... Meperidine intermediate-B .................................................................................................................................................... Meperidine intermediate-C .................................................................................................................................................... Metazocine ............................................................................................................................................................................ Methadone ............................................................................................................................................................................. Methadone intermediate ........................................................................................................................................................ Metopon ................................................................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................... Morphine ................................................................................................................................................................................ Oripavine ............................................................................................................................................................................... Thebaine ................................................................................................................................................................................ Dihydroetorphine ................................................................................................................................................................... Levo-alphacetylmethadol ....................................................................................................................................................... Oxymorphone ........................................................................................................................................................................ Noroxymorphone ................................................................................................................................................................... VerDate Sep<11>2014 19:23 Mar 22, 2023 Jkt 259001 PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1 Schedule 9812 9813 9814 9815 9816 9821 9822 9823 9824 9825 9826 9827 9830 9831 9832 9833 9834 9835 9836 9837 9838 9840 9843 9845 9847 9850 1100 1105 1205 1631 1724 2125 2270 2315 2550 7365 I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II 7379 7460 7471 8333 8501 8603 9010 9020 9041 9050 9059 9120 9143 9150 9170 9180 9190 9193 9210 9220 9226 9230 9232 9233 9234 9240 9250 9254 9260 9273 9300 9330 9333 9334 9648 9652 9668 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II 17627 Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices Controlled substance Drug code Phenazocine .......................................................................................................................................................................... Thiafentanil ............................................................................................................................................................................ Piminodine ............................................................................................................................................................................. Racemethorphan ................................................................................................................................................................... Racemorphan ........................................................................................................................................................................ Alfentanil ................................................................................................................................................................................ Remifentanil ........................................................................................................................................................................... Sufentanil ............................................................................................................................................................................... Carfentanil ............................................................................................................................................................................. Tapentadol ............................................................................................................................................................................. Bezitramide ............................................................................................................................................................................ Fentanyl ................................................................................................................................................................................. Moramide-intermediate .......................................................................................................................................................... The company plans to import analytical reference standards for distribution to its customers for research and analytics purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized in 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2023–05916 Filed 3–22–23; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1169] Importer of Controlled Substances Application: Purisys, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 24, 2023. Such persons may also file a written request for a hearing on the application on or before April 24, 2023. ADDRESSES: The Drug Enforcement Administration requires that all ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:23 Mar 22, 2023 Jkt 259001 comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on February 15, 2023, Purisys, LLC, 1550 Olympic Drive, Athens, Georgia 30601–1602, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance Marihuana Extract ........... Marihuana ........................ Tetrahydrocannabinols .... Nabilone .......................... Phenylacetone ................. Ecgonine .......................... Levorphanol ..................... Thebaine .......................... Opium, raw ...................... Opium, powdered ............ Opium, granulated ........... PO 00000 Frm 00112 Fmt 4703 Noroxymorphone ............. Poppy Straw Concentrate Tapentadol ...................... II II II II II II II II II II II II II Drug code Schedule 9668 9670 9780 II II II The company plans to import Opium, Raw (9600), Opium, Powered (9639) and Opium, Granulated (9640) to manufacture an Active Pharmaceutical Ingredient (API) only for distribution to its customers. The company plans to import Phenylacetone (8501) and Poppy Straw Concentrate (9670), to bulk manufacture other Controlled substances for distribution to its customers. The company plans to import impurities of buprenorphine that have been determined by DEA to be captured under Thebaine (9333). In reference to Marihuana Extract (7350), Marihuana (7360) and Tetrahydrocannabinols (7370) the company plans to import as synthetic. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2023–05939 Filed 3–22–23; 8:45 am] BILLING CODE P Drug code Schedule 7350 7360 7370 7379 8501 9180 9220 9333 9600 9639 9640 I I I II II II II II II II II Sfmt 4703 Controlled substance 9715 9729 9730 9732 9733 9737 9739 9740 9743 9780 9800 9801 9802 Schedule DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1145] Importer of Controlled Substances Application: Myonex Inc. Drug Enforcement Administration, Justice. AGENCY: E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17623-17627]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05916]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1159]


Importer of Controlled Substances Application: Lipomed

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Lipomed has applied to be registered as an importer of basic 
class(es) of controlled substance(s). Refer to Supplementary 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
April 24, 2023. Such persons may also file a written request for a 
hearing on the application on or before April 24, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 9, 2023 Lipomed, 150 Cambridepark Drive, 
Suite 705, Cambridge, Massachusetts 02140-2300, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
            Controlled substance              Drug code      Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).........        1233  I
Cathinone..................................        1235  I
Methcathinone..............................        1237  I
4-Fluoro-N-methylcathinone (4-FMC).........        1238  I
Pentedrone ([alpha]-                               1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone)....        1248  I
4-Methyl-N-ethylcathinone (4-MEC)..........        1249  I
Naphyrone..................................        1258  I
N-Ethylamphetamine.........................        1475  I
N,N-Dimethylamphetamine....................        1480  I
Fenethylline...............................        1503  I
Aminorex...................................        1585  I
4-Methylaminorex (cis isomer)..............        1590  I
Gamma Hydroxybutyric Acid..................        2010  I
Methaqualone...............................        2565  I
Mecloqualone...............................        2572  I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)        6250  I
 indole).
SR-18 (Also known as RCS-8) (1-                    7008  I
 Cyclohexylethyl-3-(2-methoxyphenylacetyl)
 indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-           7010  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 ([1-(5-Fluoro-           7011  I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone).
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-       7012  I
 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
 carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)....        7019  I
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-       7020  I
 1H-indazole-3-carboxamido)-3,3-
 dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-         7021  I
 (4-fluorobenzyl)-1Hindazole-3-carboxamido)-
 3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-       7023  I
 yl)-1-pentyl-1H-indazole-)3-carboxamide.
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-        7024  I
 yl](naphthalen-1-yl)methanone).
5F-AB-PINACA (N-(1-amino-3methyl-1-oxobutan-       7025  I
 2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
 carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-       7031  I
 2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
 carboxamide).
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-            7032  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-           7033  I
 indazole-3-carboxamido)-3-methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-            7034  I
 fluoropentyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-             7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-         7036  I
 carboxamido) 3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-            7042  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-               7044  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3-methylbutanoate).
N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-          7047  I
 indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-       7048  I
 1H-indazole-3-carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-        7049  I
 (5-fluoropentyl)-1H-indazole-3-
 carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)        7081  I
 indole).
1-(5-Fluoropentyl)-1H-indazole-3-                  7083  I
 carboxamide.
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-          7085  I
 phenylpropan-2-yl)-1H-pyrrolo[2,3-
 b]pyridine-3-carboxamide).
4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-                7089  I
 BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-
 BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-
 phenylpropan-2-yl)-1H-indazole-3-
 carboximide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-       7104  I
 methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3-         7118  I
 (1-naphthoyl)indole).

[[Page 17624]]

 
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)         7122  I
 indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-           7144  I
 tetramethylcyclopropyl)methanone).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)....        7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-          7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)         7201  I
 indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)         7203  I
 indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-             7221  I
 fluoropentyl)-1H-indole-3-carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-         7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-        7225  I
 1H-indole-3-carboxylate).
4-methyl-alpha-ethylaminopentiophenone (4-         7245  I
 MEAP).
N-ethylhexedrone...........................        7246  I
Alpha-ethyltryptamine......................        7249  I
Ibogaine...................................        7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-               7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-                    7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.................        7315  I
2,5-Dimethoxy-4-(n)-                               7348  I
 propylthiophenethylamine (2C-T-7).
Marihuana extract..........................        7350  I
Marihuana..................................        7360  I
Tetrahydrocannabinols......................        7370  I
Parahexyl..................................        7374  I
Mescaline..................................        7381  I
2C-T-2, (2-(4-Ethylthio-2,5-                       7385  I
 dimethoxyphenyl) ethanamine).
3,4,5-Trimethoxyamphetamine................        7390  I
4-Bromo-2,5-dimethoxyamphetamine...........        7391  I
4-Bromo-2,5-dimethoxyphenethylamine........        7392  I
4-Methyl-2,5-dimethoxyamphetamine..........        7395  I
2,5-Dimethoxyamphetamine...................        7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)         7398  I
 indole).
2,5-Dimethoxy-4-ethylamphetamine...........        7399  I
3,4-Methylenedioxyamphetamine..............        7400  I
5-Methoxy-3,4-methylenedioxyamphetamine....        7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine....        7402  I
3,4-Methylenedioxy-N-ethylamphetamine......        7404  I
3,4-Methylenedioxymethamphetamine..........        7405  I
4-Methoxyamphetamine.......................        7411  I
5-Methoxy-N-N-dimethyltryptamine...........        7431  I
Alpha-methyltryptamine.....................        7432  I
Bufotenine.................................        7433  I
Diethyltryptamine..........................        7434  I
Dimethyltryptamine.........................        7435  I
Psilocybin.................................        7437  I
Psilocyn...................................        7438  I
5-Methoxy-N,N-diisopropyltryptamine........        7439  I
4-chloro-alpha-pyrrolidinovalerophenone (4-        7443  I
 chloro-a-PVP).
N-Ethyl-1-phenylcyclohexylamine............        7455  I
1-(1-Phenylcyclohexyl)pyrrolidine..........        7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine......        7470  I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine.....        7473  I
N-Ethyl-3-piperidyl benzilate..............        7482  I
N-Methyl-3-piperidyl benzilate.............        7484  I
N-Benzylpiperazine.........................        7493  I
4-MePPP (4-Methyl-                                 7498  I
 alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl)             7508  I
 ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)              7509  I
 ethanamine).
2C-H (2-(2,5-Dimethoxyphenyl) ethanamine)..        7517  I
2C-I (2-(4-iodo-2,5-dimethoxyphenyl)               7518  I
 ethanamine).
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl)             7519  I
 ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl)             7521  I
 ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)         7524  I
 ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5-                   7532  I
 dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)......        7535  I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-        7536  I
 N-(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-       7537  I
 N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-       7538  I
 (2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N-                   7540  I
 methylcathinone).
Butylone...................................        7541  I
Pentylone..................................        7542  I
N-Ethylpentylone, ephylone (1-(1,3-                7543  I
 benzodioxol-5-yl)-2-(ethylamino)-pentan-1-
 one).
[alpha]-PHP, alpha-Pyrrolidinohexanophenone        7544  I
[alpha]-PVP (alpha-                                7545  I
 pyrrolidinopentiophenone).
[alpha]-PBP (alpha-pyrrolidinobutiophenone)        7546  I
PV8, alpha-Pyrrolidinoheptaphenone.........        7548  I
AM-694 (1-(5-Fluoropentyl)-3-(2-                   7694  I
 iodobenzoyl) indole).

[[Page 17625]]

 
Norfentanyl................................        8366  I
Acetyldihydrocodeine.......................        9051  I
Benzylmorphine.............................        9052  I
Codeine-N-oxide............................        9053  I
Cyprenorphine..............................        9054  I
Desomorphine...............................        9055  I
Etorphine (except HCl).....................        9056  I
Codeine methylbromide......................        9070  I
Dihydromorphine............................        9145  I
Difenoxin..................................        9168  I
Heroin.....................................        9200  I
Hydromorphinol.............................        9301  I
Methyldesorphine...........................        9302  I
Methyldihydromorphine......................        9304  I
Morphine methylbromide.....................        9305  I
Morphine methylsulfonate...................        9306  I
Morphine-N-oxide...........................        9307  I
Myrophine..................................        9308  I
Nicocodeine................................        9309  I
Nicomorphine...............................        9312  I
Normorphine................................        9313  I
Pholcodine.................................        9314  I
Thebacon...................................        9315  I
Acetorphine................................        9319  I
Drotebanol.................................        9335  I
U-47700 (3,4-dichloro-N-[2-                        9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                       9551  I
 dimethylamino)cyclohexylmethyl]benzamide)).
MT-45 (1-cyclohexyl-4-(1,2-                        9560  I
 diphenylethyl)piperazine)).
Acetylmethadol.............................        9601  I
Allylprodine...............................        9602  I
Alphacetylmethadol except levo-                    9603  I
 alphacetylmethadol.
Alphameprodine.............................        9604  I
Alphamethadol..............................        9605  I
Benzethidine...............................        9606  I
Betacetylmethadol..........................        9607  I
Betameprodine..............................        9608  I
Betamethadol...............................        9609  I
Betaprodine................................        9611  I
Clonitazene................................        9612  I
Dextromoramide.............................        9613  I
Diampromide................................        9615  I
Diethylthiambutene.........................        9616  I
Dimenoxadol................................        9617  I
Dimepheptanol..............................        9618  I
Dimethylthiambutene........................        9619  I
Dioxaphetyl butyrate.......................        9621  I
Dipipanone.................................        9622  I
Ethylmethylthiambutene.....................        9623  I
Etonitazene................................        9624  I
Etoxeridine................................        9625  I
Furethidine................................        9626  I
Hydroxypethidine...........................        9627  I
Ketobemidone...............................        9628  I
Levomoramide...............................        9629  I
Levophenacylmorphan........................        9631  I
Morpheridine...............................        9632  I
Noracymethadol.............................        9633  I
Norlevorphanol.............................        9634  I
Normethadone...............................        9635  I
Norpipanone................................        9636  I
Phenadoxone................................        9637  I
Phenampromide..............................        9638  I
Phenoperidine..............................        9641  I
Piritramide................................        9642  I
Proheptazine...............................        9643  I
Properidine................................        9644  I
Racemoramide...............................        9645  I
Trimeperidine..............................        9646  I
Phenomorphan...............................        9647  I
Propiram...................................        9649  I
1-Methyl-4-phenyl-4-propionoxypiperidine...        9661  I
1-(2-Phenylethyl)-4-phenyl-4-                      9663  I
 acetoxypiperidine.
Tilidine...................................        9750  I
Acryl fentanyl (N-(1-phenethylpiperidin-4-         9811  I
 yl)-N-phenylacrylamide).

[[Page 17626]]

 
Para-Fluorofentanyl........................        9812  I
3-Methylfentanyl...........................        9813  I
Alpha-Methylfentanyl.......................        9814  I
Acetyl-alpha-methylfentanyl................        9815  I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-        9816  I
 4-yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-        9821  I
 yl)-N-phenylacetamide).
Butyryl Fentanyl...........................        9822  I
Para-fluorobutyryl fentanyl................        9823  I
4-Fluoroisobutyryl fentanyl (N-(4-                 9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-4-
 yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-         9825  I
 phenylacetamide.
Para-chloroisobutyryl fentanyl.............        9826  I
Isobutyryl fentanyl........................        9827  I
Beta-hydroxyfentanyl.......................        9830  I
Beta-hydroxy-3-methylfentanyl..............        9831  I
Alpha-methylthiofentanyl...................        9832  I
3-Methylthiofentanyl.......................        9833  I
Furanyl fentanyl (N-(1-phenethylpiperidin-4-       9834  I
 yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl...............................        9835  I
Beta-hydroxythiofentanyl...................        9836  I
Para-methoxybutyryl fentanyl...............        9837  I
Ocfentanil.................................        9838  I
Valeryl fentanyl...........................        9840  I
N-(1-phenethylpiperidin-4-yl)-N-                   9843  I
 phenyltetrahydrofuran-2-carboxamide).
Cyclopropyl Fentanyl.......................        9845  I
Cyclopentyl fentanyl.......................        9847  I
Fentanyl related-compounds as defined in 21        9850  I
 CFR 1308.11(h).
Amphetamine................................        1100  II
Methamphetamine............................        1105  II
Lisdexamfetamine...........................        1205  II
Phenmetrazine..............................        1631  II
Methylphenidate............................        1724  II
Amobarbital................................        2125  II
Pentobarbital..............................        2270  II
Secobarbital...............................        2315  II
Glutethimide...............................        2550  II
Dronabinol in an oral solution in a drug           7365  II
 product approved for marketing by the U.S.
 Food and Drug Administration (FDA).
Nabilone...................................        7379  II
1-Phenylcyclohexylamine....................        7460  II
Phencyclidine..............................        7471  II
ANPP (4-Anilino-N-phenethyl-4-piperidine)..        8333  II
Phenylacetone..............................        8501  II
1-Piperidinocyclohexanecarbonitrile........        8603  II
Alphaprodine...............................        9010  II
Anileridine................................        9020  II
Cocaine....................................        9041  II
Codeine....................................        9050  II
Etorphine HCl..............................        9059  II
Dihydrocodeine.............................        9120  II
Oxycodone..................................        9143  II
Hydromorphone..............................        9150  II
Diphenoxylate..............................        9170  II
Ecgonine...................................        9180  II
Ethylmorphine..............................        9190  II
Hydrocodone................................        9193  II
Levomethorphan.............................        9210  II
Levorphanol................................        9220  II
Isomethadone...............................        9226  II
Meperidine.................................        9230  II
Meperidine-intermediate-A..................        9232  II
Meperidine intermediate-B..................        9233  II
Meperidine intermediate-C..................        9234  II
Metazocine.................................        9240  II
Methadone..................................        9250  II
Methadone intermediate.....................        9254  II
Metopon....................................        9260  II
Dextropropoxyphene, bulk (non-dosage forms)        9273  II
Morphine...................................        9300  II
Oripavine..................................        9330  II
Thebaine...................................        9333  II
Dihydroetorphine...........................        9334  II
Levo-alphacetylmethadol....................        9648  II
Oxymorphone................................        9652  II
Noroxymorphone.............................        9668  II

[[Page 17627]]

 
Phenazocine................................        9715  II
Thiafentanil...............................        9729  II
Piminodine.................................        9730  II
Racemethorphan.............................        9732  II
Racemorphan................................        9733  II
Alfentanil.................................        9737  II
Remifentanil...............................        9739  II
Sufentanil.................................        9740  II
Carfentanil................................        9743  II
Tapentadol.................................        9780  II
Bezitramide................................        9800  II
Fentanyl...................................        9801  II
Moramide-intermediate......................        9802  II
------------------------------------------------------------------------

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytics purposes. 
Placement of these drug codes onto the company's registration does not 
translate into automatic approval of subsequent permit applications to 
import controlled substances. Approval of permit applications will 
occur only when the registrant's business activity is consistent with 
what is authorized in 21 U.S.C. 952(a)(2). Authorization will not 
extend to the import of Food and Drug Administration-approved or non-
approved finished dosage forms for commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-05916 Filed 3-22-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.